Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Measurable Disease”

136 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 136 results

Testing effectiveness (Phase 2)Study completedNCT04133948
What this trial is testing

Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma

Who this might be right for
Malignant Melanoma Stage III
The Netherlands Cancer Institute 44
Early research (Phase 1)Study completedNCT00634452
What this trial is testing

Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma

Who this might be right for
Hodgkin's Lymphomas
Bristol-Myers Squibb 22
Post-approval studies (Phase 4)WithdrawnNCT02415257
What this trial is testing

Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

Who this might be right for
Vestibular Schwannoma
Lund University
Early research (Phase 1)Ended earlyNCT01284335
What this trial is testing

A Safety Study in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 234
Not applicableLooking for participantsNCT06693830
What this trial is testing

CtDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Who this might be right for
LymphomaLymphoma, B-CellDiffuse Large B Cell Lymphoma+2 more
Hua-Jay J Cherng, MD 40
Testing effectiveness (Phase 2)Ended earlyNCT00272909
What this trial is testing

Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)

Who this might be right for
Stroke
Daiichi Sankyo 43
Early research (Phase 1)Study completedNCT01449370
What this trial is testing

Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer

Who this might be right for
Metastatic Solid Tumors
Millennium Pharmaceuticals, Inc. 125
Testing effectiveness (Phase 2)Looking for participantsNCT06511882
What this trial is testing

Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD

Who this might be right for
Acute Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute 37
Not applicableStudy completedNCT01116869
What this trial is testing

China CellSearch Study

Who this might be right for
Metastatic Breast CancerBenign Breast Disease
Johnson & Johnson Medical, China 500
Testing effectiveness (Phase 2)Study completedNCT01255137
What this trial is testing

Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer

Who this might be right for
Adrenal Cortex Neoplasms
National Cancer Institute (NCI) 13
Not applicableStudy completedNCT00493727
What this trial is testing

Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria

Who this might be right for
DiabetesProteinuria
US Department of Veterans Affairs 15
Testing effectiveness (Phase 2)Looking for participantsNCT06974786
What this trial is testing

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

Who this might be right for
Multiple Myeloma, Newly DiagnosedMultiple Myeloma (MM)
SCRI Development Innovations, LLC 100
Not applicableNot Yet RecruitingNCT06090786
What this trial is testing

Kinetics and Impact on Survival of MRD in AML Patients Receiving Azacitidine and Venetoclax

Who this might be right for
AML, AdultMinimal Residual Disease
Gruppo Italiano Malattie EMatologiche dell'Adulto 225
Not applicableStudy completedNCT05798182
What this trial is testing

Ultrasound Markers of Systemic Inflammation

Who this might be right for
Inflammation ProcessEndothelial DysfunctionVasomotor Arterial Disorder+2 more
Osijek University Hospital 61
Testing effectiveness (Phase 2)Study completedNCT00523159
What this trial is testing

IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease

Who this might be right for
Renal Cell Carcinoma
Immatics Biotechnologies GmbH 68
Testing effectiveness (Phase 2)Study completedNCT00936702
What this trial is testing

Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary

Who this might be right for
Carcinoma of Unknown Primary Origin
Alliance for Clinical Trials in Oncology 46
Post-approval studies (Phase 4)Ended earlyNCT04506086
What this trial is testing

Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
B-precursor Acute Lymphoblastic Leukemia
Amgen 10
Not applicableStudy completedNCT00527553
What this trial is testing

The Effect of Eggs and Egg Products on Macular Pigment

Who this might be right for
Age-related Macular Degeneration
Maastricht University Medical Center 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07392970
What this trial is testing

Motixafortide for MRD Sensitization in AML

Who this might be right for
Acute Myeloid LeukemiaMeasurable Residual Disease
Washington University School of Medicine 10
Testing effectiveness (Phase 2)Study completedNCT00744900
What this trial is testing

Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
University Hospital, Brest 45
Load More Results